» Articles » PMID: 26474595

Evaluation of a Modified Karnofsky Score to Assess Physical and Psychological Wellbeing of Cats in a Hospital Setting

Overview
Date 2015 Oct 18
PMID 26474595
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives The Karnofsky score (KS) modified for cats, a scoring system to rate health and quality of life (QOL) in cats, is used in clinical trials, but its reliability and validity are yet to be determined. The present study aims to evaluate the scientific robustness of the KS when adapted for use in a hospital setting. Methods A list of variables to consider during the physical examination, which informs the clinician's score (CS) part of the KS, was added and clinicians were allowed to choose a score anywhere between 0 and 50. The Karnofsky QOL questionnaire was adapted for use in a hospital setting. F-tests with Bonferroni correction and Spearman rank correlation coefficients were used to evaluate reliability and validity of the KS to assess the health and wellbeing of cats in a hospital setting. The records of 54 feline immunodeficiency virus-positive cats, which were recruited for a clinical trial and hospitalised for 6 weeks, were reviewed. Four veterinarians scored the CS, and one veterinarian and a veterinary nurse assessed the QOL score. Results Mean absolute difference between observers was significantly larger for the CS than for the QOL score ( P <0.001) and two veterinarians scored significantly higher than the remaining two veterinarians ( P <0.001). Inter-observer correlation ranged from 0.45-0.75 for the CS. For the QOL score, the absolute difference between observers was small, no significant difference was found between observers and a high degree of inter-observer correlation was noted (r = 0.91). Conclusions and relevance The results indicate low inter-observer reliability for the CS, requiring additional modifications to this part of the KS. The QOL score seems more reliable, and the questionnaire may serve as a reliable tool in the assessment of QOL in cats in a hospital setting. Consequently, further adaptation of the KS is mandatory when simultaneous assessment of both the cat's clinical health and perceived wellbeing is required.

Citing Articles

Clinical Follow-Up and Postmortem Findings in a Cat That Was Cured of Feline Infectious Peritonitis with an Oral Antiviral Drug Containing GS-441524.

Krentz D, Zwicklbauer K, Felten S, Bergmann M, Dorsch R, Hofmann-Lehmann R Viruses. 2022; 14(9).

PMID: 36146845 PMC: 9506130. DOI: 10.3390/v14092040.


Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524.

Krentz D, Zenger K, Alberer M, Felten S, Bergmann M, Dorsch R Viruses. 2021; 13(11).

PMID: 34835034 PMC: 8621566. DOI: 10.3390/v13112228.


Methods of Assessment of the Welfare of Shelter Cats: A Review.

Vojtkovska V, Voslarova E, Vecerek V Animals (Basel). 2020; 10(9).

PMID: 32872242 PMC: 7552334. DOI: 10.3390/ani10091527.


2020 AAFP Feline Retrovirus Testing and Management Guidelines.

Little S, Levy J, Hartmann K, Hofmann-Lehmann R, Hosie M, Olah G J Feline Med Surg. 2020; 22(1):5-30.

PMID: 31916872 PMC: 11135720. DOI: 10.1177/1098612X19895940.


Relationship between total thyroxine, thyroid palpation and a clinical index in hyperthyroid and healthy cats and cats with other diseases.

Wehner A, Koehler I, Ramspott S, Hartmann K J Feline Med Surg. 2018; 21(8):741-749.

PMID: 30328752 PMC: 10814298. DOI: 10.1177/1098612X18799462.


References
1.
Litster A, Wu C, Constable P . Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter. J Am Vet Med Assoc. 2012; 241(2):218-26. DOI: 10.2460/javma.241.2.218. View

2.
Hartmann K, Kuffer M . Karnofsky's score modified for cats. Eur J Med Res. 1998; 3(1-2):95-8. View

3.
Hartmann K, Kuffer M, Balzarini J, Naesens L, Goldberg M, Erfle V . Efficacy of the acyclic nucleoside phosphonates (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) and 9-(2-phosphonylmethoxyethyl)adenine (PMEA) against feline immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 17(2):120-8. DOI: 10.1097/00042560-199802010-00004. View

4.
Spofford N, Lefebvre S, McCune S, Niel L . Should the veterinary profession invest in developing methods to assess quality of life in healthy dogs and cats?. J Am Vet Med Assoc. 2013; 243(7):952-6. DOI: 10.2460/javma.243.7.952. View

5.
de Mari K, Maynard L, Sanquer A, Lebreux B, Eun H . Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med. 2004; 18(4):477-82. DOI: 10.1892/0891-6640(2004)18<477:teorfi>2.0.co;2. View